investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genetic Predictors of AML Treatment Response
Richard Aplenc
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Thomas Lehrnbecher
Frankfurt University of Applied Sciences
Frankfurt am Main, Germany
Lillian Sung
Hospital for Sick Children
Toronto, Canada
Brenda Gibson
Royal Hospital for Sick Children
Glasgow, United Kingdom
Richard Aplenc
Children's Hospital of Philadelphia
Philadelphia, United States
Related projects
Thomas J O'Hare
Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia
Leukaemia
Hematology and hematologic malignancies
Aaron D Schimmer
Targeting Mitochondrial Protein Synthesis with Tigecycline for the Treatment of l
Leukaemia
Hematology and hematologic malignancies
David A Fruman
TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance
Leukaemia
Hematology and hematologic malignancies
Terzah M Horton
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
Leukaemia
Pediatric oncology or childhood cancer
Javier Adachi
Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions
Leukaemia
Hematology and hematologic malignancies
Monica M Bertagnolli
Alliance for Clinical Trials in Oncology Operations Center
Leukaemia
Hematology and hematologic malignancies
Effie W Petersdorf
Hematopoietic Stem Cell and Cord Blood Transplantation
Leukaemia
Hematology and hematologic malignancies
Javier Adachi
Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru
Leukaemia
Hematology and hematologic malignancies
Targeting BCL6 in Tyrosine Kinase-Driven Leukemia
Leukaemia
Hematology and hematologic malignancies
